Chevening - Jeffrey Cheah Foundation Scholar Heads to Cambridge

 Jun Hao Tan, recipient of the Chevening-Jeffrey Cheah Foundation (JCF) scholar 2021-22, will be pursuing the Master of Philosophy in Therapeutic Sciences at the University of Cambridge. 

The pharmacy graduate aspires to elevate his understanding particularly on advances that may lead to the discovery and development of innovative new treatments that would significantly benefit patients in Malaysia and around the world. 

Driven by a keen interest in the realm of biomedical research and therapeutics development and with the support of the JCF Jun Hao stated, “I will be able to access cutting-edge knowledge and learn advanced research techniques in therapeutic sciences at the University of Cambridge. I hope to seize the opportunities for further research training at the world-leading research institutes housed in the Jeffrey Cheah Biomedical Centre in Cambridge, particularly the Milner Therapeutics Institute.”

Jun Hao shared perseverance and determination are the keys to staying motivated in achieving his goals. “Among the many lessons I have learnt from the ongoing COVID-19 pandemic, is how vital regional and global collaborations are in the development of new lifesaving therapeutics, as well as the importance of enhancing the self-sufficiency of developing nations in the development and manufacture of biopharmaceutical products that save lives,” said Jun Hao. 

The Cambridge Academy of Therapeutic Sciences is closely associated with the Milner Therapeutics Institute, a major translational organisation located in the Jeffrey Cheah Biomedical Centre (JCBC) – a key research centre in one of the largest biotech clusters outside the United States. 

Located alongside the Addenbrooke’s Hospital, Royal Papworth Hospital, and AstraZeneca World Headquarters and the world-famous Laboratory of Molecular Biology from which 14 Nobel Prizes have emanated, JCBC is renowned for research and development on immunology and stem cells, and for translation of pioneering research in therapeutics and immunology into practical application.

Established in 1983, the prestigious Chevening Scholarships were pioneered by UK’s Department of Foreign, Commonwealth and Development Office with the aim to support UK foreign policy priorities and create lasting positive relationships with future leaders and decision-makers throughout the world.

Some 1,800 Chevening scholarships are offered annually to prospects across 160 countries, with more than 55,000 alumni holding up leading positions in their countries to date.

Jeffrey Cheah Foundation (JCF) became a Chevening Partner in 2018 to support outstanding scholars pursuing Masters course in the fields of medical, physical or life sciences, at either the University of Cambridge, the University of Oxford, or Lancaster University.